Safety of retroviral gene marking with a truncated NGF receptor

被引:153
作者
Bonini, C [1 ]
Grez, M
Traversari, C
Ciceri, F
Marktel, S
Ferrari, G
Dinauer, M
Sadat, M
Aiuti, A
Deola, S
Radrizzani, M
Hagenbeek, A
Apperley, J
Ebeling, S
Martens, A
Kolb, HJ
Weber, M
Lotti, F
Grande, A
Weissinger, E
Bueren, JA
Lamana, M
Falkenburg, JHF
Heemskerk, MHM
Austin, T
Kornblau, S
Marini, F
Benati, C
Magnani, Z
Cazzaniga, S
Toma, S
Gallo-Stampino, C
Introna, M
Slavin, S
Greenberg, PD
Bregni, M
Mavilio, F
Bordignon, C
机构
[1] Ist Sci HS Raffaele, Canc Immunotherapy & Gene Therapy Program, Milan, Italy
[2] Ist Sci HS Raffaele, Bone Marrow Transplantat Unit, Milan, Italy
[3] Univ Vita & Salute, Milan, Italy
[4] Georg Speyer Haus, Frankfurt, Germany
[5] Molmed SpA, Milan, Italy
[6] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, Fac Med, London, England
[7] HS Raffaele Telethon, Inst Gene Therapy, Milan, Italy
[8] Indiana Univ, Sch Med, Wells Ctr Pediat Res, Indianapolis, IN USA
[9] Univ Med Ctr, Dept Haematol, Utrecht, Netherlands
[10] GSF, Natl Res Ctr Environm & Hlth, Munich, Germany
[11] Univ Modena, Sch Med, Dept Biomed Sci, I-41100 Modena, Italy
[12] Hannover Med Sch, D-3000 Hannover, Germany
[13] CIEMAT, Hematopoiet Gene Therapy Program, Fdn Marcelino Botin, E-28040 Madrid, Spain
[14] Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands
[15] Stem Cells Inc, Liver Stem Cell Program, Palo Alto, CA USA
[16] Univ Texas, MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA
[17] Ist Ric Farmacol Mario Negri, Mol Immunohematol Lab, Dept Immunol & Cell Biol, Milan, Italy
[18] Hadassah Univ Hosp, Dept Bone Marrow Transplantat & Canc Immunotherap, IL-91120 Jerusalem, Israel
[19] Univ Washington, Fred Hutchinson Canc Res Ctr, Program Immunol, Seattle, WA 98195 USA
[20] Univ Washington, Dept Immunol & Med, Seattle, WA 98195 USA
关键词
D O I
10.1038/nm0403-367
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:367 / 369
页数:3
相关论文
共 5 条
  • [1] HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia
    Bonini, C
    Ferrari, G
    Verzeletti, S
    Servida, P
    Zappone, E
    Ruggieri, L
    Ponzoni, M
    Rossini, S
    Mavilio, F
    Traversari, C
    Bordignon, C
    [J]. SCIENCE, 1997, 276 (5319) : 1719 - 1724
  • [2] TRANSFER OF THE HSV-TK GENE INTO DONOR PERIPHERAL-BLOOD LYMPHOCYTES FOR IN-VIVO MODULATION OF DONOR ANTITUMOR IMMUNITY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    BORDIGNON, C
    BONINI, C
    VERZELETTI, S
    NOBILI, N
    MAGGIONI, D
    TRAVERSARI, C
    GIAVAZZI, R
    SERVIDA, P
    ZAPPONE, E
    BENAZZI, E
    BERNARDI, M
    PORTA, F
    FERRARI, G
    MAVILIO, F
    ROSSINI, S
    BLAESE, RM
    CANDOTTI, F
    [J]. HUMAN GENE THERAPY, 1995, 6 (06) : 813 - 819
  • [3] A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
    Hacein-Bey-Abina, S
    von Kalle, C
    Schmidt, M
    Le Deist, F
    Wulffraat, N
    McIntyre, E
    Radford, I
    Villeval, JL
    Fraser, CC
    Cavazzana-Calvo, M
    Fischer, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03) : 255 - 256
  • [4] Murine leukemia induced by retroviral gene marking
    Li, ZX
    Düllmann, J
    Schiedlmeier, B
    Schmidt, M
    von Kalle, C
    Meyer, J
    Forster, M
    Stocking, C
    Wahlers, A
    Frank, O
    Ostertag, W
    Kühlcke, K
    Eckert, HG
    Fehse, B
    Baum, C
    [J]. SCIENCE, 2002, 296 (5567) : 497 - 497
  • [5] ROSENBERG N, 1997, RETROVIRUSES, P413